The oxidase activity of normal serum is due to the presence of the blue copper protein, ceruloplasmin. This is an a-globulin of molecular weight 151,000 containing 8 copper atoms per molecule (1) . Its physiological substrate, if any, is unknown (2) , but it has a weak oxidase activity for compounds that can be oxidized to quinone or quinone imines (3) . The copper atoms in the protein appear to be arranged in functional pairs, and it seems probable that a specific function exists that will be shown to depend upon the unique chemical nature of the protein, as has already been demonstrated for another copper protein, tyrosinase (4) .
The concentration of ceruloplasmin in serum can be measured by estimating light absorption at 605 mp, before and after the destruction of the copper-protein bond with cyanide, by immunochemical techniques, or by measuring the oxidation of paraphenylene diamine (or related compounds) either in a Warburg flask or a spectrophotometer (4) . These three methods all give comparable results, although measuring different properties of the protein: the copper-protein bond, the antigenic site, and the catalytic center. The most commonly used laboratory method to determine ceruloplasmin is the estimation of the color formed during the oxidation of paraphenylene diamine, or its dimethyl derivative (5-7). The result can be placed on a semiquantitative basis by comparison with those obtained by use of known amounts of purified ceruloplasmin, which within limits, gives an activity proportional to the amount of ceruloplasmin present (3) . It has been suggested, however, that there are high-and lowmolecular-weight compounds present in normal plasma that inhibit the oxidase properties of ceruloplasmin; Akerfeldt (8) believed the predominant one was ascorbic acid. Compounds with sulfhydryl (SH) groups have also been implicated (9) and so has serum albumin (10). Richterich (11) Normal serum was obtained from donors attending the Regional Blood Transfusion Center; lipemic samples were discarded. Wilson's-disease serum was obtained from patients in whom the diagnosis seemed to be beyond doubt. In one patient, C.B., the ceruloplasmin concentration was relatively high, 18 mg per 100 ml. The diagnosis was confirmed by radiocopper studies (15) . After one year of treatment with penicillamine, the ceruloplasmin level had fallen to less than 1 mg per 100 ml. In another patient, P.V., the serum was studied on two occasions a year apart. On the first, when she was receiving treatment with penicillamine, the ceruloplasmin level was 1 mg per 100 ml. A year later, after treatment had been discontinued for several months, the ceruloplasmin concentration had risen to 13 mg per 100 ml. Samples of cord blood from six newborn babies were also investigated, and in addition, serum from three patients with hepatic cirrhosis.
RESULTS
Twenty-seven normal sera were studied; the mean oxidase activity was 0. Samples from six normal sera were treated by acid dialysis (pH 3) to remove copper and discharge the oxidase activity of the ceruloplasmin. The untreated serum was then added to the "apo- serum" in the proportions previously used, and the tests were repeated. This procedure was next carried out with "aposerum" and whole ceruloplasmin and also with serum dialyzed against bicarbonate buffer only and whole ceruloplasmin.
The results are given in Table V . These show that the six sera, when added to purified ceruloplasmin, potentiated the oxidase activity slighlty more than the average for the whole group, that after acid dialysis the "aposerum" inhibited the oxidase activity of the whole serum in a manner simliar to, but slightly greater than Wilson's-disease serum, that the effect of the "aposerum" on purified ceruloplasmin was also to cause inhibition, and that dialysis against the chloride: bicarbonate buffer did not result in significant loss of the oxidase properties of serum, nor cause it to inhibit purified ceruloplasmin. Finally, a preparation of purified apoceruloplasmin was mixed with untreated purified ceruloplasmin and with whole untreated serum. In both instances the apoceruloplasmin gave rise to inhibition of the oxidase activity of the mixture. In the ceruloplasmin: serum mixture, this was of the same order as in ceruloplasmin: Wilson's-disease serum mixtures, but in the ceruloplasmin: apoceruloplasmin mixture, the inhibition was in excess of the greatest found with a Wilson's-disease serum. Determination of SH groups in both normal and Wilson's disease sera gave very low results even in patients receiving penicillamine (3-mercaptovaline) . This was to be expected, as the sera were not precipitated as soon as they were drawn and no antioxidants were added.
DISCUSSION
It has been shown that under the conditions of the ceruloplasmin assay employed, the serum of patients with Wilson's disease contains an enzyme inhibitor in the nondialyzable protein fraction that is not present in normal serum. The presence of ceruloplasmin inhibitors in normal serum has been investigated by other workers (8) (9) (10) . Akerfeldt (8) believed that inhibition was caused by a lowmolecular-weight compound, probably ascorbic acid. The studies with ultrafiltrate of normal and
Wilson's-disease serum described here fully support the theory that low-moleculer-weight compounds that inhibit the oxidase properties of ceruloplasmin are present in serum. Under the conditions of the test, it seems unlikely that ascorbic acid could have survived, and recent work with purified ceruloplasmin has shown that it probably has no oxidase activity towards ascorbic acid (16) . As the inhibitor was present in similar concentrations in both normal and Wilson's-disease serum, its nature was not relevant to the present study. No evidence was found to support the theory that SH groups that may be present in plasma, either naturally occurring or after the administration of penicillamine, inhibit the oxidation of p-phenylenediamine by ceruloplasmin. Experiments with concentrated protein residue did not demonstrate any significant inhibitor action for ceruloplasmin by the nondiffusible fraction of normal serum, although Leach, Cohen, and Heath (10) have argued in favor of SH radicals on normal albumin having such an action. The concentrates of Wilson's-disease se-rum, however, gave rise to a significant inhibition in the oxidation of dimethyl-p-phenylenediamine by normal ceruloplasmin. As it is extremely unlikely that there are two abnormalities of the serum proteins in a genetically determined disease, it would seem reasonable to exclude the possibility of an abnormal albumin in Wilson's-disease serum on purely theoretical grounds. Alternative explanations are a) that a metallic ion or other low-molecular-weight compound is present in the serum and is complexed to one or more of the serum proteins, b) that an abnormal ceruloplasmin is present that inhibits the normal ceruloplasmin by substrate competition, or c) that a normal (or possibly abnormal) ceruloplasmin precursor is present that inhibits by a similar mechanism.
As all ceruloplasmin assays were conducted in the presence of disodium ethylenediaminetetraacetic acid (EDTA), it is unlikely that metallic ions were concerned with the reaction, and this probably precludes a role for the nonceruloplasmin copper in Wilson's-disease serum. The search for an abnormal ceruloplasmin in Wilson's disease, bringing this condition into line with the hemoglobinopathies and with the abnormal pseudocholinesterase (suxamethonium sensitivity) disease, has not so far been successful. Although the presence of more than one ceruloplasmin in normal serum has been established (7, (17) (18) (19) , it has not so far been possible to demonstrate an abnormal component in the serum of patients with Wilson's disease by using either starch gel or column chromatography (20) . Hitherto, all attempts to identify an abnormal ceruloplasmin in Wilson's-disease serum have depended on the oxidase activity or the blue color of the protein. However, if the liver of these patients retained the ability to synthesize the protein moiety of ceruloplasmin and either lacked the enzyme necessary to incorporate copper at the active enzyme centers, as has been suggested elsewhere (15) , or produced a structurally abnormal protein lacking binding centers for the metal, the presence of an apoceruloplasmin in the serum would not be detectable by the techniques so far employed. The data that have been presented here show that purified apoceruloplasmin at concentrations in the "physiological" range inhibits both purified normal ceruloplasmin and ceruloplasmin in whole serum to the same degree as does Wilson's-disease serum. Furthermore, when the ceruloplasmin in whole serum has been rendered enzymatically inactive by removal of its copper atoms, it inhibits both purified ceruloplasmin and ceruloplasmin in whole serum to a similar extent.
This evidence does not prove that the inhibitor present in the protein fraction of Wilson's disease serum is apoceruloplasmin, but is compatible with it. Proof can only come by isolation and identification of such a protein, but as the markers, blue color and oxidase activity, are absent, this may prove extremely difficult, especially if the protein is structurally abnormal so that it cannot incorporate copper to become enzymatically active.
If this hypothesis is eventually proved, it would place the primary genetic defect in Wilson's disease not in an absence of the template necessary for the synthesis of ceruloplasmin, but in the presence of an abnormal template or the absence of an "incorporating enzyme." Such a defect has already been postulated by Osborn, Roberts, and Walshe (15), who suggested that the deficiency of a single enzyme which mediated a two-stage reaction, the concentration of copper in the liver and then its incorporation into cerulopasmin, was compatible with their radiocopper studies. These showed a delayed and defective uptake of radiocopper by the liver in Wilson's disease and confirmed the well-established inability of patients with Wilson's disease to incorporate copper into ceruloplasmin (21, 22 6. Apoceruloplasmin and whole serum from which ceruloplasmin copper had been removed by dialysis at pH 3 both inhibited normal ceruloplasmin and ceruloplasmin in whole normal serum to the same extent as did Wilson's-disease serum.
7. The possibility is suggested that an apoceruloplasmin may be present in the serum of patients with Wilson's disease, and such a protein could not be detected by estimating either absorption at 605 mb& or by determining oxidase activity.
